callisto healthcare ltd
callisto healthcare ltd Company Information
Company Number
07767324
Next Accounts
7 days late
Industry
Residential care activities for the elderly and disabled
Shareholders
ganymede care ltd
Group Structure
View All
Contact
Registered Address
1 battersea square, london, SW11 3RZ
callisto healthcare ltd Estimated Valuation
Pomanda estimates the enterprise value of CALLISTO HEALTHCARE LTD at £128.8k based on a Turnover of £152.5k and 0.84x industry multiple (adjusted for size and gross margin).
callisto healthcare ltd Estimated Valuation
Pomanda estimates the enterprise value of CALLISTO HEALTHCARE LTD at £403.6k based on an EBITDA of £63.1k and a 6.4x industry multiple (adjusted for size and gross margin).
callisto healthcare ltd Estimated Valuation
Pomanda estimates the enterprise value of CALLISTO HEALTHCARE LTD at £0 based on Net Assets of £-3m and 3.03x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Callisto Healthcare Ltd Overview
Callisto Healthcare Ltd is a live company located in london, SW11 3RZ with a Companies House number of 07767324. It operates in the residential care activities for the elderly and disabled sector, SIC Code 87300. Founded in September 2011, it's largest shareholder is ganymede care ltd with a 100% stake. Callisto Healthcare Ltd is a established, micro sized company, Pomanda has estimated its turnover at £152.5k with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Callisto Healthcare Ltd Health Check
Pomanda's financial health check has awarded Callisto Healthcare Ltd a 2 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 4 areas for improvement. Company Health Check FAQs
1 Strong
3 Regular
4 Weak
Size
annual sales of £152.5k, make it smaller than the average company (£2.7m)
- Callisto Healthcare Ltd
£2.7m - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Callisto Healthcare Ltd
- - Industry AVG
Production
with a gross margin of 38.5%, this company has a comparable cost of product (38.5%)
- Callisto Healthcare Ltd
38.5% - Industry AVG
Profitability
an operating margin of 41.4% make it more profitable than the average company (10.7%)
- Callisto Healthcare Ltd
10.7% - Industry AVG
Employees
with 4 employees, this is below the industry average (67)
4 - Callisto Healthcare Ltd
67 - Industry AVG
Pay Structure
on an average salary of £22.6k, the company has an equivalent pay structure (£22.6k)
- Callisto Healthcare Ltd
£22.6k - Industry AVG
Efficiency
resulting in sales per employee of £38.1k, this is equally as efficient (£38.1k)
- Callisto Healthcare Ltd
£38.1k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Callisto Healthcare Ltd
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Callisto Healthcare Ltd
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Callisto Healthcare Ltd
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (32 weeks)
0 weeks - Callisto Healthcare Ltd
32 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 167.9%, this is a higher level of debt than the average (46.6%)
167.9% - Callisto Healthcare Ltd
46.6% - Industry AVG
CALLISTO HEALTHCARE LTD financials
Callisto Healthcare Ltd's latest turnover from March 2023 is estimated at £152.5 thousand and the company has net assets of -£3 million. According to their latest financial statements, Callisto Healthcare Ltd has 4 employees and maintains cash reserves of £93.1 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 0 | 0 | 123,986 | 143,004 | 160,000 | 175,903 | 214,214 | 214,214 | 81,590 | |||
| Other Income Or Grants | 0 | 0 | 0 | 0 | ||||||||
| Cost Of Sales | 0 | 0 | 0 | 0 | ||||||||
| Gross Profit | 0 | 123,986 | 143,004 | 160,000 | ||||||||
| Admin Expenses | 4,938 | 4,890 | 8,051 | 938 | ||||||||
| Operating Profit | -4,848 | -4,938 | 119,096 | 134,953 | 159,062 | 182,885 | 209,777 | 209,526 | 81,214 | |||
| Interest Payable | 0 | 112,111 | 121,645 | 140,558 | 164,476 | 176,493 | 192,467 | 209,147 | 81,214 | |||
| Interest Receivable | 0 | 0 | 67,156 | 21,420 | 0 | 0 | 0 | 0 | 0 | |||
| Pre-Tax Profit | -4,848 | -117,049 | 64,607 | -2,873,473 | -5,414 | 6,392 | 17,310 | 379 | 0 | |||
| Tax | 0 | 0 | 0 | 0 | -111 | -1,479 | -3,537 | -75 | 0 | |||
| Profit After Tax | -4,848 | -117,049 | 64,607 | -2,873,473 | -5,525 | 4,913 | 13,773 | 304 | 0 | |||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Retained Profit | -4,848 | -117,049 | 64,607 | -2,873,473 | -5,525 | 4,913 | 13,773 | 304 | 0 | |||
| Employee Costs | 0 | |||||||||||
| Number Of Employees | 4 | 4 | 4 | 4 | 4 | |||||||
| EBITDA* | -4,848 | -4,938 | 119,096 | 134,953 | 159,062 | 182,885 | 209,777 | 209,526 | 81,214 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 3,114,823 | 3,114,823 | 3,114,823 | 3,114,823 | 3,114,823 | 3,114,823 | 3,114,823 | 6,004,111 | 6,004,111 | 6,004,111 | 6,004,111 | 6,004,111 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 3,114,823 | 3,114,823 | 3,114,823 | 3,114,823 | 3,114,823 | 3,114,823 | 3,114,823 | 6,004,111 | 6,004,111 | 6,004,111 | 6,004,111 | 6,004,111 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group Debtors | 1,130,195 | 1,130,195 | 1,130,195 | 3,470,661 | 3,470,661 | 3,470,661 | 3,346,886 | 3,203,882 | 3,083,882 | 3,057,980 | 3,134,766 | 3,413,235 |
| Misc Debtors | 105,290 | 102,938 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 93,145 | 38 | 0 | 0 | 1,337 | 14,883 | 3,039 | 8,652 | 8,573 | 3,385 | 5,715 | 10,237 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 1,328,630 | 1,233,171 | 1,130,195 | 3,470,661 | 3,471,998 | 3,485,544 | 3,349,925 | 3,212,534 | 3,092,455 | 3,061,365 | 3,140,481 | 3,423,472 |
| total assets | 4,443,453 | 4,347,994 | 4,245,018 | 6,585,484 | 6,586,821 | 6,600,367 | 6,464,748 | 9,216,645 | 9,096,566 | 9,065,476 | 9,144,592 | 9,427,583 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 2,747,670 | 3,236,701 | 3,679,996 | 4,095,903 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4,367,188 | 4,789,062 | 105,469 |
| Trade Creditors | 0 | 0 | 7,307,665 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 7,452,481 | 7,410,683 | 0 | 9,648,101 | 9,644,590 | 6,770,636 | 6,210,593 | 5,645,611 | 5,103,232 | 4,652,884 | 4,327,884 | 4,327,884 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 7,530 | 6,580 | 5,630 | 4,680 | 4,680 | 27,461 | 27,461 | 27,572 | 28,440 | 31,326 | 27,341 | 99,698 |
| total current liabilities | 7,460,011 | 7,417,263 | 7,313,295 | 9,652,781 | 9,649,270 | 9,545,767 | 9,474,755 | 9,353,179 | 9,227,575 | 9,051,398 | 9,144,287 | 4,533,051 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4,894,531 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4,894,531 |
| total liabilities | 7,460,011 | 7,417,263 | 7,313,295 | 9,652,781 | 9,649,270 | 9,545,767 | 9,474,755 | 9,353,179 | 9,227,575 | 9,051,398 | 9,144,287 | 9,427,582 |
| net assets | -3,016,558 | -3,069,269 | -3,068,277 | -3,067,297 | -3,062,449 | -2,945,400 | -3,010,007 | -136,534 | -131,009 | 14,078 | 305 | 1 |
| total shareholders funds | -3,016,558 | -3,069,269 | -3,068,277 | -3,067,297 | -3,062,449 | -2,945,400 | -3,010,007 | -136,534 | -131,009 | 14,078 | 305 | 1 |
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||
| Operating Profit | -4,848 | -4,938 | 119,096 | 134,953 | 159,062 | 182,885 | 209,777 | 209,526 | 81,214 | |||
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | -111 | -1,479 | -3,537 | -75 | 0 | |||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 2,352 | 102,938 | -2,340,466 | 0 | 0 | 123,775 | 143,004 | 120,000 | 25,902 | -76,786 | -278,469 | 3,413,235 |
| Creditors | 0 | -7,307,665 | 7,307,665 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 950 | 950 | 950 | 0 | -22,781 | 0 | -111 | -868 | -2,886 | 3,985 | -72,357 | 99,698 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | -4,848 | -27,719 | -4,679 | -8,162 | 38,083 | 152,618 | 287,011 | 415,563 | -3,232,323 | |||
| Investing Activities | ||||||||||||
| capital expenditure | ||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | -2,889,288 | 0 | 0 | 0 | 0 | 6,004,111 |
| cash flow from investments | ||||||||||||
| Financing Activities | ||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4,367,188 | -421,874 | 4,683,593 | 105,469 |
| Group/Directors Accounts | 41,798 | 7,410,683 | -9,648,101 | 3,511 | 2,873,954 | 560,043 | 564,982 | 542,379 | 450,348 | 325,000 | 0 | 4,327,884 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4,894,531 | 4,894,531 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||
| interest | 0 | -112,111 | -54,489 | -119,138 | -164,476 | -176,493 | -192,467 | -209,147 | -81,214 | |||
| cash flow from financing | 3,511 | 2,761,843 | 505,554 | 445,844 | 377,903 | -4,243,333 | -289,341 | -420,085 | 9,246,671 | |||
| cash and cash equivalents | ||||||||||||
| cash | 93,107 | 38 | 0 | -1,337 | -13,546 | 11,844 | -5,613 | 79 | 5,188 | -2,330 | -4,522 | 10,237 |
| overdraft | 0 | 0 | 0 | 0 | -2,747,670 | -489,031 | -443,295 | -415,907 | 4,095,903 | 0 | 0 | 0 |
| change in cash | 93,107 | 38 | 0 | -1,337 | 2,734,124 | 500,875 | 437,682 | 415,986 | -4,090,715 | -2,330 | -4,522 | 10,237 |
callisto healthcare ltd Credit Report and Business Information
Callisto Healthcare Ltd Competitor Analysis
Perform a competitor analysis for callisto healthcare ltd by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in SW11 area or any other competitors across 12 key performance metrics.
callisto healthcare ltd Ownership
CALLISTO HEALTHCARE LTD group structure
Callisto Healthcare Ltd has 1 subsidiary company.
Ultimate parent company
1 parent
CALLISTO HEALTHCARE LTD
07767324
1 subsidiary
callisto healthcare ltd directors
Callisto Healthcare Ltd currently has 4 directors. The longest serving directors include Mr Anoop Patel (Sep 2011) and Dr Narinder Dhandsa (Sep 2011).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Anoop Patel | 70 years | Sep 2011 | - | Director | |
| Dr Narinder Dhandsa | 68 years | Sep 2011 | - | Director | |
| Mr Surindar Dhandsa | United Kingdom | 71 years | Sep 2011 | - | Director |
| Mr Vuk Latincic | England | 36 years | Jul 2022 | - | Director |
P&L
March 2023turnover
152.5k
+9%
operating profit
63.1k
0%
gross margin
38.6%
+1.32%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2023net assets
-3m
-0.02%
total assets
4.4m
+0.02%
cash
93.1k
+2450.18%
net assets
Total assets minus all liabilities
callisto healthcare ltd company details
company number
07767324
Type
Private limited with Share Capital
industry
87300 - Residential care activities for the elderly and disabled
incorporation date
September 2011
age
13
incorporated
UK
ultimate parent company
accounts
Small Company
last accounts submitted
March 2023
previous names
N/A
accountant
-
auditor
-
address
1 battersea square, london, SW11 3RZ
Bank
BARCLAYS BANK PLC
Legal Advisor
-
callisto healthcare ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to callisto healthcare ltd. Currently there are 1 open charges and 0 have been satisfied in the past.
callisto healthcare ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for CALLISTO HEALTHCARE LTD. This can take several minutes, an email will notify you when this has completed.
callisto healthcare ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
